cadila pharmaceuticals
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for cadila pharmaceuticals from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 22 transactions, with a transaction quantity of 45240.1 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 264 912588.1 0
- 2026 22 45240.1 0
Bill of lading data
< 1/15 >- Trade date 2026/02/21 B/L No. 0406585
- Suppliers zhejiang guobang pharma co.ltd. Buyers cadila pharmaceuticals
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 71000
- Hs code 29419090 Product tags azithromycin,ip usp
- Product description AZITHROMYCIN IP USP AZITHROMYCIN IP USP Expand
- Trade date 2026/02/13 B/L No. 5587326
- Suppliers recordati industria chimica e farmaceuticas s.p.a. Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area Italy Purchas area India
- Weight —— Amount 63200
- Hs code 29420090 Product tags bat,methenamine hippurate
- Product description METHENAMINE HIPPURATE BATCH NO 26100066 26100067 METHENAMINE HIPPURATE BATCH NO 26100066 26100067 Expand
- Trade date 2026/02/13 B/L No. 1717186
- Suppliers recordati industria chimica e farmaceuticas s.p.a. Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area Italy Purchas area India
- Weight —— Amount 55300
- Hs code 29420090 Product tags bat,methenamine hippurate
- Product description METHENAMINE HIPPURATE BATCH NO 26100066 26100067 METHENAMINE HIPPURATE BATCH NO 26100066 26100067 Expand
- Trade date 2026/02/11 B/L No. 7887067
- Suppliers zhejiang guobang pharma co.ltd. Buyers cadila pharmaceuticals
- POLs —— PODs mumbai (ex bombay)
- Supply area China Purchas area India
- Weight —— Amount 25875
- Hs code 29419090 Product tags roxithromycin
- Product description ROXITHROMYCIN IP EP ROXITHROMYCIN IP EP Expand
- Trade date 2026/02/07 B/L No. 0020522
- Suppliers .henan kangtai pharmaceutical g Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area China Purchas area India
- Weight —— Amount 7425
- Hs code 29419060 Product tags norfloxacin,bat
- Product description NORFLOXACIN USP BATCH NO 251147 NORFLOXACIN USP BATCH NO 251147 Expand
- Trade date 2026/02/05 B/L No. 3027227
- Suppliers livzon group fuzhou puxing pharmaceutical co.ltd. Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area China Purchas area India
- Weight —— Amount 2700
- Hs code 29419090 Product tags bat,tobramycin sulphate
- Product description TOBRAMYCIN SULPHATE USP BATCH NO SB2512002 TOBRAMYCIN SULPHATE USP BATCH NO SB2512002 Expand
- Trade date 2026/01/31 B/L No. 3651868
- Suppliers mdnf Buyers cadila pharmaceuticals
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 136000
- Hs code 29269090 Product tags dicyanamide,sodium
- Product description SODIUM DICYANAMIDE SODIUM DICYANAMIDE Expand
- Trade date 2026/01/24 B/L No. 1140328
- Suppliers mdnf Buyers cadila pharmaceuticals
- POLs —— PODs mumbai (ex bombay)
- Supply area China Purchas area India
- Weight —— Amount 61250
- Hs code 29162090 Product tags cyclohexane carboxylic acid,isopropyl
- Product description TRANS 4 ISOPROPYL CYCLOHEXANE CARBOXYLIC ACID TRANS 4 ISOPROPYL CYCLOHEXANE CARBOXYLIC ACID Expand
- Trade date 2026/01/24 B/L No. 8154132
- Suppliers sm biomed sdn bhd Buyers cadila pharmaceuticals
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area Malaysia Purchas area India
- Weight —— Amount 18200
- Hs code 29415000 Product tags leva,erythromycin base,bulk drug
- Product description ERYTHROMYCIN BASE USP IH RELEVANT BULK DRUG S ERYTHROMYCIN BASE USP IH RELEVANT BULK DRUG S Expand
- Trade date 2026/01/24 B/L No. 8284383
- Suppliers sm biomed sdn bhd Buyers cadila pharmaceuticals
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area Malaysia Purchas area India
- Weight —— Amount 18200
- Hs code 29415000 Product tags leva,erythromycin base,bulk drug
- Product description ERYTHROMYCIN BASE USP IH RELEVANT BULK DRUG S ERYTHROMYCIN BASE USP IH RELEVANT BULK DRUG S Expand
- Trade date 2026/01/23 B/L No. 4266410
- Suppliers zhejiang guobang pharma co.ltd. Buyers cadila pharmaceuticals
- POLs —— PODs mumbai (ex bombay)
- Supply area China Purchas area India
- Weight —— Amount 156200
- Hs code 29419090 Product tags azithromycin
- Product description AZITHROMYCIN USP IP AZITHROMYCIN USP IP Expand
- Trade date 2026/01/23 B/L No. 2153650
- Suppliers yangzhou aurisco pharmaceutical co.ltd. Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area China Purchas area India
- Weight —— Amount 7425
- Hs code 30049099 Product tags bat,bempedoic acid
- Product description BEMPEDOIC ACID BATCH NO BECA 250501FA21 BECA 251201 BECA250303FA01BEMPEDOIC ACID BATCH NO BECA 250501FA21 BECA 251201 BECA Expand
- Trade date 2026/01/23 B/L No. 3524336
- Suppliers dead sea bromine ltd. Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area Israel Purchas area India
- Weight —— Amount 40600
- Hs code 28161010 Product tags bat,magnesium hydroxide
- Product description MAGNESIUM HYDROXIDE BATCH NO 308243061 308253043 MAGNESIUM HYDROXIDE BATCH NO 308243061 308253043 Expand
- Trade date 2026/01/13 B/L No. 8786584
- Suppliers mdnf Buyers cadila pharmaceuticals
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 8550
- Hs code 29039990 Product tags ra c,orid,loro,flu,benzo
- Product description PARA CHLOROBENZO TRIFLUORID PARA CHLOROBENZO TRIFLUORID Expand
- Trade date 2026/01/11 B/L No. 6622664
- Suppliers chemo s a Buyers cadila pharmaceuticals
- POLs —— PODs ahmedabad
- Supply area Switzerland Purchas area India
- Weight —— Amount 19200
- Hs code 29420034 Product tags famotidine,bat
- Product description FAMOTIDINE BATCH NO FM025101 FAMOTIDINE BATCH NO FM02101 Expand
Partners
Total 254- Rank Company Transactions Per Detail
- 1 cadila pharmaceuticals ltd. russiasupplier,they trade on 2025-11-07 584 1.75% >
- 2 cadila pharmaceuticals indiabuyer,they trade on 2023-11-29 304 0.91% >
- 3 zhejiang guobang pharma co.ltd. chinasupplier,they trade on 2026-02-21 98 0.29% >
- 4 aurorium llc united statesbuyer,they trade on 2025-10-17 94 0.28% >
- 5 hebei chengxin co ltd yuanzhao road yuanshi co chinasupplier,they trade on 2026-01-09 82 0.25% > +View All
Products
Total 582- Products Transactions Per Detail
-
bat
262 33.33% > -
iu
72 9.16% > -
drum
70 8.91% > -
vitride
69 8.78% > -
mixture
63 8.02% >
+View All
Hscode rank
Total 476- HSCode Name Transactions Per Detail
- HS 29094990 72 9.16% >
- HS 29419090 57 7.25% >
- HS 29420090 45 5.73% >
- HS 29309099 44 5.6% >
- HS 29411010 39 4.96% > +View All
Trading Area
Total 36- Area Transactions Per Detail
- china 702 2.10% >
- india 577 1.73% >
- russia 383 1.15% >
- united states 247 0.74% >
- italy 102 0.31% > +View All
cadila pharmaceuticals is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bat，iu，drum.
According to the 52wmb.com global trade database, as of 2026-02-21, the company has completed 33398 international trades,
with its main trading regions covering china，india,russia etc.
The core products include HS29094990，HS29419090，HS29420090 etc,
and its main trading partners are cadila pharmaceuticals ltd.，cadila pharmaceuticals，zhejiang guobang pharma co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cadila pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool